Fundz

Newron Pharmaceuticals secures EUR 5.5 million through an investor group as part of up to EUR 38 million financing to support the ENIGMA-TRS Phase 3 program.

PRIVATESep 08, 2026

Amount Raised

€5.5 Million

Round Type

Venture

MilanBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Newron Pharmaceuticals announced an investment of EUR 5.5 million from an investor group as part of a larger EUR 38 million financing. This funding will strengthen the company's financial position as it advances its ENIGMA-TRS Phase 3 program. The investor group initially subscribed to a total of EUR 15 million and is expected to contribute more in the future. The new shares will be listed on multiple exchanges starting today.

Quick answer

Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raised €5.5 Million in a funding round, dated September 8, 2026. Newron Pharmaceuticals S.p.A. & EA Pharma Ltd is based in Milan, Lombardy, Italy.

How much did Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raise?
Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raised €5.5 Million in a funding round on September 8, 2026.
What does Newron Pharmaceuticals S.p.A. & EA Pharma Ltd do?
Newron Pharmaceuticals S.p.A. is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system.
Where is Newron Pharmaceuticals S.p.A. & EA Pharma Ltd based and how big is it?
Newron Pharmaceuticals S.p.A. & EA Pharma Ltd is based in Milan, Lombardy, Italy. Fundz records about 23 employees.
Who are the decision-makers at Newron Pharmaceuticals S.p.A. & EA Pharma Ltd?
Fundz holds 3 contacts at Newron Pharmaceuticals S.p.A. & EA Pharma Ltd, including the Chief Financial Officer, IAB Member. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Newron Pharmaceuticals S.p.A. & EA Pharma Ltd that raised within 45 days of this round, from Fundz verified event records.

  • Disc raised $422M (Post-IPO Equity) on October 20, 2026.
  • Acta Pharmaceuticals raised $24M (Seed) on October 15, 2026.
  • Os Therapies raised $7.2M on October 15, 2026.
  • Ensho Therapeutics raised $7.3M on October 2, 2026.
  • Breye Therapeutics raised $77M (Series A) on September 29, 2026.
  • Orvida Pharma raised an undisclosed amount on September 15, 2026.

Who to call at Newron Pharmaceuticals S.p.A. & EA Pharma Ltd, and when

A new round usually means Newron Pharmaceuticals S.p.A. & EA Pharma Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Newron Pharmaceuticals S.p.A. & EA Pharma Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Newron Pharmaceuticals S.p.A. & EA Pharma Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Newron Pharmaceuticals S.p.A. & EA Pharma Ltd

Location

Milan, Lombardy, Italy

About

Newron Pharmaceuticals S.p.A. is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. EA Pharma Co., Ltd. is a subsidiary of Eisai Co., Ltd. focused on pharmaceutical development.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsRoberto G., Chief Financial Officer, IAB Member hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Newron Pharmaceuticals S.p.A. & EA Pharma Ltd's next move

See what Strategic adds

Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.